Your browser doesn't support javascript.
loading
Single-cell RNA sequencing reveals that VIM and IFITM3 are vital targets of Dengzhan Shengmai capsule to protect against cerebral ischemic injury.
Cao, Guang-Zhao; Hou, Jing-Yi; Zhou, Rui; Tian, Liang-Liang; Wang, Mao-Lin; Zhang, Yi; Xu, He; Yang, Hong-Jun; Zhang, Jing-Jing.
Afiliación
  • Cao GZ; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China. Electronic address: cgzbucm2020@163.com.
  • Hou JY; Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, 100700, China. Electronic address: hjy_2016@126.com.
  • Zhou R; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China. Electronic address: zhourui677000@163.com.
  • Tian LL; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China. Electronic address: llt0791@163.com.
  • Wang ML; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China. Electronic address: 17805008158@163.com.
  • Zhang Y; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China. Electronic address: zy701223@sina.com.
  • Xu H; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China. Electronic address: hxu@icmm.ac.cn.
  • Yang HJ; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China; Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, 100700, China. Electronic address: hongjun0420@vip.sina.com.
  • Zhang JJ; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China; Chinese Institute for Brain Research, Beijing, 102206, China. Electronic address: zjj4785@163.com.
J Ethnopharmacol ; 311: 116439, 2023 Jul 15.
Article en En | MEDLINE | ID: mdl-37004745

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Lesiones Encefálicas / Daño por Reperfusión / Isquemia Encefálica / Fármacos Neuroprotectores / Accidente Cerebrovascular / Accidente Cerebrovascular Isquémico Tipo de estudio: Prognostic_studies Idioma: En Revista: J Ethnopharmacol Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Lesiones Encefálicas / Daño por Reperfusión / Isquemia Encefálica / Fármacos Neuroprotectores / Accidente Cerebrovascular / Accidente Cerebrovascular Isquémico Tipo de estudio: Prognostic_studies Idioma: En Revista: J Ethnopharmacol Año: 2023 Tipo del documento: Article